Compare AUDC & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUDC | MGTX |
|---|---|---|
| Founded | 1992 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.7M | 1.2B |
| IPO Year | 2000 | 2018 |
| Metric | AUDC | MGTX |
|---|---|---|
| Price | $10.07 | $13.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $12.50 | ★ $24.57 |
| AVG Volume (30 Days) | 84.7K | ★ 668.3K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.54% | N/A |
| EPS Growth | N/A | ★ 33.02 |
| EPS | N/A | ★ 1.30 |
| Revenue | N/A | ★ $81,391,000.00 |
| Revenue This Year | $4.24 | $141.38 |
| Revenue Next Year | $2.18 | N/A |
| P/E Ratio | $23.06 | ★ $9.88 |
| Revenue Growth | N/A | ★ 144.57 |
| 52 Week Low | $6.95 | $6.62 |
| 52 Week High | $10.86 | $15.35 |
| Indicator | AUDC | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 42.15 |
| Support Level | $8.82 | $12.39 |
| Resistance Level | $10.31 | $15.33 |
| Average True Range (ATR) | 0.31 | 0.53 |
| MACD | -0.02 | -0.21 |
| Stochastic Oscillator | 67.56 | 15.25 |
AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.